Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jun;94(6):448-456.
doi: 10.1136/jnnp-2022-329342. Epub 2023 Feb 17.

Structural and functional changes in the retina in Parkinson's disease

Affiliations
Review

Structural and functional changes in the retina in Parkinson's disease

Jordan N Alves et al. J Neurol Neurosurg Psychiatry. 2023 Jun.

Abstract

Parkinson's disease is caused by degeneration of dopaminergic neurons, originating in the substantia nigra pars compacta and characterised by bradykinesia, rest tremor and rigidity. In addition, visual disorders and retinal abnormalities are often present and can be identified by decreased visual acuity, abnormal spatial contrast sensitivity or even difficulty in complex visual task completion. Because of their early onset in patients with de novo Parkinson's disease, the anatomical retinal changes and electrophysiological modification could be valuable markers even at early stages of the disease. However, due to the concomitant occurrence of normal ageing, the relevance and specificity of these predictive values can be difficult to interpret. This review examines retinal dysfunction arising in Parkinson's disease. We highlight the electrophysiological delays and decreased amplitude in the electroretinography recorded in patients and animal models. We relate this to coexisting anatomical changes such as retinal nerve fibre layer and macular thinning, measured using optical coherence tomography, and show that functional measures are more consistent overall than optical coherence-measured structural changes. We review the underlying chemical changes seen with loss of retinal dopaminergic neurons and the effect of levodopa treatment on the retina in Parkinson's disease. Finally, we consider whether retinal abnormalities in Parkinson's disease could have a role as potential markers of poorer outcomes and help stratify patients at early stages of the disease. We emphasise that retinal measures can be valuable, accessible and cost-effective methods in the early evaluation of Parkinson's disease pathogenesis with potential for patient stratification.

Keywords: ERG; NEUROPHYSIOLOGY; PARKINSON'S DISEASE; VISION.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Portion of a human retina from Helga et al. Copyrights information: Attribution-Noncommercial 4.0 International Creative Commons license (CC BY-NC 4.0).
Figure 2
Figure 2
Different types of electroretinogram recording devices. (A) Burian-Allen corneal electrode. (B) Dawson-Trick-Litzkow electrode. (C) RETeval sensor strip electrodes. (D) Optically pumped magnetometers.
Figure 3
Figure 3
Diagram of basic electroretinograms defined by the ISCEV Standard from McCulloch et al. Reprinted with permission from [Springer Nature]: [Springer] [Documenta Ophthalmologica] [ISCEV Standard for full-field clinical electroretinography (2015 update), Daphne L. McCulloch et al), [License number: 5352540818755] (2015).

References

    1. Urwyler P, Nef T, Killen A, et al. Visual complaints and visual hallucinations in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20(3):318–22. doi: 10.1016/j.parkreldis.2013.12.009. - DOI - PubMed
    1. Ekker MS, Janssen S, Seppi K, et al. Ocular and visual disorders in Parkinson’s disease: Common but frequently overlooked. Parkinsonism Relat Disord. 2017;40:1–10. doi: 10.1016/j.parkreldis.2017.02.014. - DOI - PubMed
    1. Davidsdottir S, Cronin-Golomb A, Lee A. Visual and spatial symptoms in Parkinson’s disease. Vision Res. 2005;45(10):1285–96. doi: 10.1016/j.visres.2004.11.006. - DOI - PubMed
    1. Archibald NK, Clarke MP, Mosimann UP, et al. Visual symptoms in Parkinson’s disease and Parkinson’s disease dementia. Mov Disord. 2011;26(13):2387–95. doi: 10.1002/mds.23891. - DOI - PubMed
    1. Hamedani AG, Abraham DS, Maguire MG, et al. Visual Impairment Is More Common in Parkinson’s Disease and Is a Risk Factor for Poor Health Outcomes. Mov Disord. 2020;35(9):1542–49. doi: 10.1002/mds.28182. - DOI - PMC - PubMed

Publication types

MeSH terms